Global Medical REIT (GMRE) to Release Earnings on Wednesday

Global Medical REIT (NYSE:GMRE) is anticipated to announce its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $1.02 per share and revenue of $37.4420 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 9:00 AM ET.

Global Medical REIT Price Performance

GMRE opened at $35.93 on Monday. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 1.65. The stock has a market capitalization of $481.81 million, a P/E ratio of -143.72 and a beta of 1.18. The stock has a 50-day moving average price of $35.16 and a 200-day moving average price of $34.31. Global Medical REIT has a 12-month low of $29.05 and a 12-month high of $45.75.

Global Medical REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were given a $0.75 dividend. The ex-dividend date was Friday, December 19th. This represents a $3.00 dividend on an annualized basis and a yield of 8.3%. Global Medical REIT’s payout ratio is presently -1,200.00%.

Institutional Investors Weigh In On Global Medical REIT

Institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP purchased a new stake in Global Medical REIT in the 2nd quarter worth approximately $241,000. Rhumbline Advisers raised its holdings in shares of Global Medical REIT by 9.7% during the second quarter. Rhumbline Advisers now owns 114,429 shares of the company’s stock valued at $793,000 after acquiring an additional 10,141 shares in the last quarter. AQR Capital Management LLC lifted its stake in Global Medical REIT by 9.5% in the first quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock worth $512,000 after acquiring an additional 5,062 shares during the period. Jones Financial Companies Lllp lifted its stake in Global Medical REIT by 23,920.0% in the first quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock worth $210,000 after acquiring an additional 23,920 shares during the period. Finally, Envestnet Asset Management Inc. boosted its holdings in Global Medical REIT by 39.5% in the second quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company’s stock valued at $184,000 after acquiring an additional 7,536 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Robert W. Baird reduced their price target on shares of Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Weiss Ratings upgraded shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $42.00.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.